David Yardeni

424 total citations
36 papers, 278 citations indexed

About

David Yardeni is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, David Yardeni has authored 36 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 17 papers in Hepatology and 5 papers in Surgery. Recurrent topics in David Yardeni's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (11 papers). David Yardeni is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (11 papers). David Yardeni collaborates with scholars based in Israel, United States and Australia. David Yardeni's co-authors include Marc G. Ghany, Kyong‐Mi Chang, Ohad Etzion, B.Z. Kaplan, Theo Heller, Crystal Y. Koh, Saeed Hamid, Minaz Mawani, Jeffrey S. Glenn and Yoav Lurie and has published in prestigious journals such as Gastroenterology, Hepatology and Scientific Reports.

In The Last Decade

David Yardeni

31 papers receiving 271 citations

Peers

David Yardeni
Doo Hyun Kim South Korea
Jialing Zhou China
Yuli Zhu China
Patrick Lehmann Germany
R. Zachoval Germany
V. Romagnoli Italy
Enas Kamal Egypt
Umang Arora India
K. Yu. Kokina Russia
Waleed K. Al‐Hamoudi Saudi Arabia
Doo Hyun Kim South Korea
David Yardeni
Citations per year, relative to David Yardeni David Yardeni (= 1×) peers Doo Hyun Kim

Countries citing papers authored by David Yardeni

Since Specialization
Citations

This map shows the geographic impact of David Yardeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Yardeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Yardeni more than expected).

Fields of papers citing papers by David Yardeni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Yardeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Yardeni. The network helps show where David Yardeni may publish in the future.

Co-authorship network of co-authors of David Yardeni

This figure shows the co-authorship network connecting the top 25 collaborators of David Yardeni. A scholar is included among the top collaborators of David Yardeni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Yardeni. David Yardeni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yardeni, David, et al.. (2025). Impact of Universal Screening for HDV in HBV‐ Infected Patients on Chronic HDV Detection Rate in Israel. Journal of Viral Hepatitis. 32(7). e70046–e70046.
2.
Etzion, Ohad, et al.. (2025). The Neuro- Cardio- and Hepato- Protective Effects of Namodenoson are Mediated by Adiponectin. Medical Research Archives. 13(2).
3.
Haim, Yulia, Nikhil S. Bhandarkar, Aryeh Shaleṿ, et al.. (2024). Circulating isomiRs May Be Superior Biomarkers Compared to Their Corresponding miRNAs: A Pilot Biomarker Study of Using isomiR-Ome to Detect Coronary Calcium-Based Cardiovascular Risk in Patients with NAFLD. International Journal of Molecular Sciences. 25(2). 890–890. 2 indexed citations
4.
5.
Etzion, Ohad, Avital Bareket‐Samish, David Yardeni, & Pnina Fishman. (2024). Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma. Biomedicines. 12(4). 848–848. 7 indexed citations
6.
Shingina, Alexandra, Ryan Chadha, Nicholas Lim, et al.. (2023). Combined heart-liver transplantation practices survey in North America: Evaluation and organ listing practices. Liver Transplantation. 29(6). 591–597. 8 indexed citations
7.
8.
Abu‐Freha, Naim, et al.. (2023). Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents. Life. 13(9). 1872–1872. 7 indexed citations
9.
Abu‐Freha, Naim, Michal Gordon, Alexander Fich, et al.. (2023). Comorbidities and Malignancy among NAFLD Patients Compared to the General Population, A Nation-Based Study. Biomedicines. 11(4). 1110–1110. 5 indexed citations
10.
Etzion, Ohad, Saeed Hamid, Yoav Lurie, et al.. (2023). Treatment of chronic hepatitis D with peginterferon lambda—the phase 2 LIMT-1 clinical trial. Hepatology. 77(6). 2093–2103. 27 indexed citations
11.
Yardeni, David, Kyong‐Mi Chang, & Marc G. Ghany. (2022). Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure. Gastroenterology. 164(1). 42–60.e6. 41 indexed citations
12.
Abu‐Freha, Naim, et al.. (2022). Liver cirrhosis in elderly patients: clinical characteristics, complications, and survival—analyses from a large retrospective study. Aging Clinical and Experimental Research. 34(9). 2217–2223. 6 indexed citations
13.
Yardeni, David & Crystal Y. Koh. (2021). Bulevirtide for HBV and HDV infections. Drugs of today. 57(7). 433–433. 11 indexed citations
14.
Abu‐Freha, Naim, et al.. (2021). Indications and Findings of Upper Endoscopies in Males and Females, Are They the Same or Different?. Journal of Clinical Medicine. 10(8). 1620–1620. 6 indexed citations
15.
Etzion, Ohad, Harel Dahari, David Yardeni, et al.. (2020). Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study. Scientific Reports. 10(1). 17820–17820. 12 indexed citations
16.
Martinello, Marianne, Alexander Churkin, Kevin Walsh, et al.. (2020). Modeling based response guided therapy in subjects with recent hepatitis C infection. Antiviral Research. 180. 104862–104862. 6 indexed citations
17.
18.
Yardeni, David, et al.. (2011). Ethnic and Gender Inequities in the Evaluation of Referred Short Children. Hormone Research in Paediatrics. 76(1). 50–55. 8 indexed citations
19.
Kaplan, B.Z., et al.. (1991). Search for intrinsic three-phase resonator. Electronics Letters. 27(10). 822–824. 1 indexed citations
20.
Kaplan, B.Z. & David Yardeni. (1990). Development of a symmetrically stabilized four‐phase oscillator and some implications. International Journal of Circuit Theory and Applications. 18(1). 71–84. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doo Hyun Kim Breakdown of academic impact, for papers by Jialing Zhou Breakdown of academic impact, for papers by Yuli Zhu Breakdown of academic impact, for papers by Patrick Lehmann Breakdown of academic impact, for papers by R. Zachoval Breakdown of academic impact, for papers by V. Romagnoli Breakdown of academic impact, for papers by Enas Kamal Breakdown of academic impact, for papers by Umang Arora Breakdown of academic impact, for papers by K. Yu. Kokina Breakdown of academic impact, for papers by Waleed K. Al‐Hamoudi
Rankless by CCL
2026